{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:12:56Z","timestamp":1783599176470,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,9]]},"DOI":"10.7759\/cureus.112325","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:12:47Z","timestamp":1783595567000},"source":"Crossref","is-referenced-by-count":0,"title":["Artificial Intelligence for the Diagnosis and Management of Neurodegenerative Diseases: A Comprehensive Review With an Emphasis on Parkinson\u2019s and Alzheimer\u2019s Diseases"],"prefix":"10.7759","author":[{"given":"SriLakshmi Pravallika","family":"Pinnelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendra Babu","family":"T","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayashankar","family":"CA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata BharatKumar","family":"Pinnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganaraja V","family":"Harikrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamsi Krishna","family":"Mudamanchu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshy T","family":"Sam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divyadharshini","family":"MS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praful","family":"Bhupathiraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul S","family":"Sucharitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkataramana","family":"Kandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Neurological disorders. public health challenges. (2006). Accessed: April 21, 2026: https:\/\/iris.who.int\/handle\/10665\/43605."},{"key":"ref2","unstructured":"Ethics and governance of artificial intelligence for health. WHO guidance. (2021). Accessed: April 21, 2026: https:\/\/iris.who.int\/handle\/10665\/341996."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma RB","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, et al.. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015, 30:1591-601. 10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.07.150","article-title":"The worldwide costs of dementia 2015 and comparisons with 2010","volume":"13","author":"Wimo A","year":"2017","unstructured":"Wimo A, Guerchet M, Ali GC, et al.. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement. 2017, 13:1-7. 10.1016\/j.jalz.2016.07.150","journal-title":"Alzheimers Dement"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack CR Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, et al.. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018, 14:535-62. 10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson's disease","volume":"30","author":"Berg D","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH, et al.. MDS research criteria for prodromal Parkinson's disease. Mov Disord. 2015, 30:1600-11. 10.1002\/mds.26431","journal-title":"Mov Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004826","article-title":"Practice guideline update summary: mild cognitive impairment","volume":"90","author":"Petersen RC","year":"2018","unstructured":"Petersen RC, Lopez O, Armstrong MJ, et al.. Practice guideline update summary: mild cognitive impairment. Neurology. 2018, 90:126-35. 10.1212\/WNL.0000000000004826","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23795","article-title":"Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts","volume":"27","author":"Jellinger KA","year":"2012","unstructured":"Jellinger KA. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. Mov Disord. 2012, 27:8-30. 10.1002\/mds.23795","journal-title":"Mov Disord"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nature14539","article-title":"Deep learning","volume":"521","author":"LeCun Y","year":"2015","unstructured":"LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015, 521:436-44. 10.1038\/nature14539","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic","volume":"14","author":"Hampel H","year":"2018","unstructured":"Hampel H, O'Bryant SE, Molinuevo JL, et al.. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat Rev Neurol. 2018, 14:639-52. 10.1038\/s41582-018-0079-7","journal-title":"Nat Rev Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws253","article-title":"Left hemispheric predominance of nigrostriatal dysfunction in Parkinson's disease","volume":"135","author":"Scherfler C","year":"2012","unstructured":"Scherfler C, Seppi K, Mair KJ, Donnemiller E, Virgolini I, Wenning GK, Poewe W. Left hemispheric predominance of nigrostriatal dysfunction in Parkinson's disease. Brain. 2012, 135:3348-54. 10.1093\/brain\/aws253","journal-title":"Brain"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2017.07.005","article-title":"A survey on deep learning in medical image analysis","volume":"42","author":"Litjens G","year":"2017","unstructured":"Litjens G, Kooi T, Bejnordi BE, et al.. A survey on deep learning in medical image analysis. Med Image Anal. 2017, 42:60-88. 10.1016\/j.media.2017.07.005","journal-title":"Med Image Anal"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2016.11","article-title":"The mPower study, Parkinson disease mobile data collected using ResearchKit","volume":"3","author":"Bot BM","year":"2016","unstructured":"Bot BM, Suver C, Neto EC, et al.. The mPower study, Parkinson disease mobile data collected using ResearchKit. Sci Data. 2016, 3:160011. 10.1038\/sdata.2016.11","journal-title":"Sci Data"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.05.1769","article-title":"The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception","volume":"9","author":"Weiner MW","year":"2013","unstructured":"Weiner MW, Veitch DP, Aisen PS, et al.. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement. 2013, 9:e111-94. 10.1016\/j.jalz.2013.05.1769","journal-title":"Alzheimers Dement"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00578","article-title":"A systematic review establishing the current state-of-the-art, the limitations, and the DESIRED checklist in studies of direct neural interfacing with robotic gait devices in stroke rehabilitation","volume":"14","author":"Lennon O","year":"2020","unstructured":"Lennon O, Tonellato M, Del Felice A, et al.. A systematic review establishing the current state-of-the-art, the limitations, and the DESIRED checklist in studies of direct neural interfacing with robotic gait devices in stroke rehabilitation. Front Neurosci. 2020, 14:578. 10.3389\/fnins.2020.00578","journal-title":"Front Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1034-x","article-title":"Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension","volume":"26","author":"Liu X","year":"2020","unstructured":"Liu X, Cruz Rivera S, Moher D, Calvert MJ, Denniston AK. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Nat Med. 2020, 26:1364-74. 10.1038\/s41591-020-1034-x","journal-title":"Nat Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30037-6","article-title":"Reporting of artificial intelligence prediction models","volume":"393","author":"Collins GS","year":"2019","unstructured":"Collins GS, Moons KG. Reporting of artificial intelligence prediction models. Lancet. 2019, 393:1577-9. 10.1016\/S0140-6736(19)30037-6","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(08)70042-7","article-title":"SPECT imaging of the dopaminergic system in (premotor) Parkinson\u2019s disease","volume":"13","author":"Booij J","year":"2007","unstructured":"Booij J, Knol RJ. SPECT imaging of the dopaminergic system in (premotor) Parkinson\u2019s disease. Parkinsonism Relat Disord. 2007, 13:S425-8. 10.1016\/S1353-8020(08)70042-7","journal-title":"Parkinsonism Relat Disord"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting PF","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, et al.. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011, 155:529-36. 10.7326\/0003-4819-155-8-201110180-00009","journal-title":"Ann Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers AJ","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006, 26:565-74. 10.1177\/0272989X06295361","journal-title":"Med Decis Making"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.64898\/2025.12.02.25340302","article-title":"Integrated genetic, molecular, and wearable sensor biomarkers enable Bayesian machine learning-driven precision stratification in Parkinson\u2019s disease: a comprehensive multi-cohort validation study","volume":"2025","author":"Tirhekar HM","year":"2025","unstructured":"Tirhekar HM, Yadav P, Bajaj C. Integrated genetic, molecular, and wearable sensor biomarkers enable Bayesian machine learning-driven precision stratification in Parkinson\u2019s disease: a comprehensive multi-cohort validation study. medRxiv. 2025, 2025:1-42. 10.64898\/2025.12.02.25340302","journal-title":"medRxiv"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1109\/TBME.2012.2183367","article-title":"Novel speech signal processing algorithms for high-accuracy classification of Parkinson's disease","volume":"59","author":"Tsanas A","year":"2012","unstructured":"Tsanas A, Little MA, McSharry PE, Spielman J, Ramig LO. Novel speech signal processing algorithms for high-accuracy classification of Parkinson's disease. IEEE Trans Biomed Eng. 2012, 59:1264-71. 10.1109\/TBME.2012.2183367","journal-title":"IEEE Trans Biomed Eng"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(20)30218-1","article-title":"Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension","volume":"2","author":"Liu X","year":"2020","unstructured":"Liu X, Cruz Rivera S, Moher D, Calvert MJ, Denniston AK. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Lancet Digit Health. 2020, 2:e537-48. 10.1016\/S2589-7500(20)30218-1","journal-title":"Lancet Digit Health"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2019.03.005","article-title":"Analysis and evaluation of handwriting in patients with Parkinson's disease using kinematic, geometrical, and non-linear features","volume":"173","author":"Rios-Urrego CD","year":"2019","unstructured":"Rios-Urrego CD, V\u00e1squez-Correa JC, Vargas-Bonilla JF, N\u00f6th E, Lopera F, Orozco-Arroyave JR. Analysis and evaluation of handwriting in patients with Parkinson's disease using kinematic, geometrical, and non-linear features. Comput Methods Programs Biomed. 2019, 173:43-52. 10.1016\/j.cmpb.2019.03.005","journal-title":"Comput Methods Programs Biomed"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000344","article-title":"A new neuroinformatics approach to personalized medicine in neurology: The Virtual Brain","volume":"29","author":"Falcon MI","year":"2016","unstructured":"Falcon MI, Jirsa V, Solodkin A. A new neuroinformatics approach to personalized medicine in neurology: The Virtual Brain. Curr Opin Neurol. 2016, 29:429-36. 10.1097\/WCO.0000000000000344","journal-title":"Curr Opin Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.0809","article-title":"Using smartphones and machine learning to quantify Parkinson disease severity: the Mobile Parkinson Disease Score","volume":"75","author":"Zhan A","year":"2018","unstructured":"Zhan A, Mohan S, Tarolli C, et al.. Using smartphones and machine learning to quantify Parkinson disease severity: the Mobile Parkinson Disease Score. JAMA Neurol. 2018, 75:876-80. 10.1001\/jamaneurol.2018.0809","journal-title":"JAMA Neurol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25902","article-title":"Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing","volume":"29","author":"Barton BR","year":"2014","unstructured":"Barton BR, Bernard B, Czernecki V, Goldman JG, Stebbins G, Dubois B, Goetz CG. Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing. Mov Disord. 2014, 29:1252-7. 10.1002\/mds.25902","journal-title":"Mov Disord"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001381","article-title":"Prognosis Research Strategy (PROGRESS) 3: prognostic model research","volume":"10","author":"Steyerberg EW","year":"2013","unstructured":"Steyerberg EW, Moons KG, van der Windt DA, et al.. Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med. 2013, 10:e1001381. 10.1371\/journal.pmed.1001381","journal-title":"PLoS Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2005.06.003","article-title":"Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI)","volume":"1","author":"Mueller SG","year":"2005","unstructured":"Mueller SG, Weiner MW, Thal LJ, et al.. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement. 2005, 1:55-66. 10.1016\/j.jalz.2005.06.003","journal-title":"Alzheimers Dement"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder EH","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, et al.. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993, 261:921-3. 10.1126\/science.8346443","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2011.01.008","article-title":"Multimodal classification of Alzheimer's disease and mild cognitive impairment","volume":"55","author":"Zhang D","year":"2011","unstructured":"Zhang D, Wang Y, Zhou L, Yuan H, Shen D. Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage. 2011, 55:856-67. 10.1016\/j.neuroimage.2011.01.008","journal-title":"Neuroimage"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadm.2018.09.002","article-title":"Alzheimer's disease: 3-dimensional MRI texture for prediction of conversion from mild cognitive impairment","volume":"10","author":"Luk CC","year":"2018","unstructured":"Luk CC, Ishaque A, Khan M, et al.. Alzheimer's disease: 3-dimensional MRI texture for prediction of conversion from mild cognitive impairment. Alzheimers Dement (Amst). 2018, 10:755-63. 10.1016\/j.dadm.2018.09.002","journal-title":"Alzheimers Dement (Amst)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2014.10.002","article-title":"Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects","volume":"104","author":"Moradi E","year":"2015","unstructured":"Moradi E, Pepe A, Gaser C, Huttunen H, Tohka J. Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects. Neuroimage. 2015, 104:398-412. 10.1016\/j.neuroimage.2014.10.002","journal-title":"Neuroimage"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist S","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, et al.. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2020, 324:772-81. 10.1001\/jama.2020.12134","journal-title":"JAMA"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease","volume":"25","author":"Preische O","year":"2019","unstructured":"Preische O, Schultz SA, Apel A, et al.. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease. Nat Med. 2019, 25:277-83. 10.1038\/s41591-018-0304-3","journal-title":"Nat Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00555","article-title":"How wearable sensors can support Parkinson\u2019s disease diagnosis and treatment: a systematic review","volume":"11","author":"Rovini E","year":"2017","unstructured":"Rovini E, Maremmani C, Cavallo F. How wearable sensors can support Parkinson\u2019s disease diagnosis and treatment: a systematic review. Front Neurosci. 2017, 11:555. 10.3389\/fnins.2017.00555","journal-title":"Front Neurosci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-28927-1","article-title":"Wearable inertial device for monitoring Parkinson's disease symptoms: a pilot study in a controlled environment","volume":"15","author":"Poleur M","year":"2025","unstructured":"Poleur M, Gidaro T, Delstanche S, et al.. Wearable inertial device for monitoring Parkinson's disease symptoms: a pilot study in a controlled environment. Sci Rep. 2025, 15:45479. 10.1038\/s41598-025-28927-1","journal-title":"Sci Rep"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2025.1737585","article-title":"Advancing Parkinson's disease detection through multi-dimensional machine learning: a comprehensive framework using wearable movement sensor analytics","volume":"16","author":"Xiang JZ","year":"2025","unstructured":"Xiang JZ, Wang QY, Fang ZB, Esquivel JA, Li XY, Xu XQ. Advancing Parkinson's disease detection through multi-dimensional machine learning: a comprehensive framework using wearable movement sensor analytics. Front Physiol. 2025, 16:1737585. 10.3389\/fphys.2025.1737585","journal-title":"Front Physiol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.21015\/vtse.v14i1.2373","article-title":"A simple and reproducible machine learning pipeline for Parkinson\u2019s disease detection using smartwatch\u2011based inertial signals","volume":"14","author":"Vu Q","year":"2026","unstructured":"Vu Q, Nguyen MC, Tran DT, Solanki VK. A simple and reproducible machine learning pipeline for Parkinson\u2019s disease detection using smartwatch\u2011based inertial signals. VFAST Trans Softw Eng. 2026, 14:350-65. 10.21015\/vtse.v14i1.2373","journal-title":"VFAST Trans Softw Eng"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-01016-w","article-title":"Optimizing wrist-worn wearable compliance with insights from two Parkinson's disease cohort studies","volume":"11","author":"Meinders MJ","year":"2025","unstructured":"Meinders MJ, Heathers L, Ho KC, et al.. Optimizing wrist-worn wearable compliance with insights from two Parkinson's disease cohort studies. NPJ Parkinsons Dis. 2025, 11:152. 10.1038\/s41531-025-01016-w","journal-title":"NPJ Parkinsons Dis"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2023.01091","article-title":"Artificial intelligence technology in Alzheimer's disease research","volume":"12","author":"Zhang W","year":"2023","unstructured":"Zhang W, Li Y, Ren W, Liu B. Artificial intelligence technology in Alzheimer's disease research. Intractable Rare Dis Res. 2023, 12:208-12. 10.5582\/irdr.2023.01091","journal-title":"Intractable Rare Dis Res"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1511350","article-title":"Application of artificial intelligence in Alzheimer's disease: a bibliometric analysis","volume":"19","author":"Song S","year":"2025","unstructured":"Song S, Li T, Lin W, Liu R, Zhang Y. Application of artificial intelligence in Alzheimer's disease: a bibliometric analysis. Front Neurosci. 2025, 19:1511350. 10.3389\/fnins.2025.1511350","journal-title":"Front Neurosci"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3390\/jdad3020026","article-title":"Counterfactual, longitudinal, and multimodal explainable artificial intelligence for magnetic resonance imaging\u2011based Alzheimer\u2019s diagnosis: a structured review","volume":"3","author":"Farha R","year":"2026","unstructured":"Farha R, Ojeme B, Khalifa F, Rahman MM. Counterfactual, longitudinal, and multimodal explainable artificial intelligence for magnetic resonance imaging\u2011based Alzheimer\u2019s diagnosis: a structured review. J Dement Alzheimer's Dis. 2026, 3:26. 10.3390\/jdad3020026","journal-title":"J Dement Alzheimer's Dis"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62590-4","article-title":"AI-driven fusion of multimodal data for Alzheimer's disease biomarker assessment","volume":"16","author":"Jasodanand VH","year":"2025","unstructured":"Jasodanand VH, Kowshik SS, Puducheri S, Romano MF, Xu L, Au R, Kolachalama VB. AI-driven fusion of multimodal data for Alzheimer's disease biomarker assessment. Nat Commun. 2025, 16:7407. 10.1038\/s41467-025-62590-4","journal-title":"Nat Commun"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2026.100545","article-title":"Screening for Alzheimer's disease in the community using an AI-driven screening platform: design of the PREDICTOM study","volume":"13","author":"Brem AK","year":"2026","unstructured":"Brem AK, Khan Z, Radermacher J, et al.. Screening for Alzheimer's disease in the community using an AI-driven screening platform: design of the PREDICTOM study. J Prev Alzheimers Dis. 2026, 13:100545. 10.1016\/j.tjpad.2026.100545","journal-title":"J Prev Alzheimers Dis"},{"key":"ref46","unstructured":"U.S. Food and Drug Administration. Artificial intelligence in software as a medical device. (2025). Accessed. April 21, 2026: https:\/\/www.fda.gov\/medical-devices\/software-medical-device-samd\/artificial-intelligence-software-medical-device."},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins GS","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015, 350:g7594. 10.1136\/bmj.g7594","journal-title":"BMJ"},{"key":"ref48","unstructured":"U.S. Food and Drug Administration. Proposed regulatory framework for modifications to artificial intelligence\/machine learning-based software as a medical device. (2026). Accessed. April 21, 2026: https:\/\/www.fda.gov\/files\/medical%20devices\/published\/US-FDA-Artificial-Intelligence-and-Machine-Learning-Discussion-...."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/484409-artificial-intelligence-for-the-diagnosis-and-management-of-neurodegenerative-diseases-a-comprehensive-review-with-an-emphasis-on-parkinsons-and-alzheimers-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:12:49Z","timestamp":1783595569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/484409-artificial-intelligence-for-the-diagnosis-and-management-of-neurodegenerative-diseases-a-comprehensive-review-with-an-emphasis-on-parkinsons-and-alzheimers-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.112325","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,9]]}}}